SVR12

1 stories · following the connections

Business

Achillion Announces Additional Phase 2 Results Including 100% SVR24 for Genotype 1 HCV After 6-Weeks of Once Daily JNJ-4178

By Nasdaq OMXApr 22, 2017, 7:00 AM UTC